Fludarabine Lymphodepletion Exposure is Associated with Toxicities after Idecabtagene-Vicleucel in Relapsed/Refractory Multiple Myeloma: Real-World Experience from the US Myeloma Immunotherapy Consortium.
Saved in:
| Title: | Fludarabine Lymphodepletion Exposure is Associated with Toxicities after Idecabtagene-Vicleucel in Relapsed/Refractory Multiple Myeloma: Real-World Experience from the US Myeloma Immunotherapy Consortium. |
|---|---|
| Authors: | Sweiss K; University of Illinois at Chicago, Chicago, Illinois. Electronic address: ksweis2@uic.edu., Wagner C; Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah., Anto E; Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah., Greene T; Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah., Sun R; University of Illinois at Chicago, Chicago, Illinois., Gonzalez R; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Puglianini OC; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Freeman C; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Ionescu F; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Patel K; The University of Texas MD Anderson Cancer Center, Houston, Texas., Ferreri C; The University of Texas MD Anderson Cancer Center, Houston, Texas., Gaballa M; The University of Texas MD Anderson Cancer Center, Houston, Texas., Shune L; The University of Kansas Medical Center, Kansas City, Kansas., McGuirk J; The University of Kansas Medical Center, Kansas City, Kansas., Sidana S; Stanford University, Palo Alto, California., Hovanky V; Stanford University, Palo Alto, California., Khouri J; Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio., Raza S; Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio., Anwer F; Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio., Dima D; Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio., Hashmi H; Medical University of South Carolina, Charleston, South Carolina., Davis J; Medical University of South Carolina, Charleston, South Carolina., Afrough A; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Hematologic Malignancies and Cellular Therapy Program, Dallas, Texas., Kaur G; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Hematologic Malignancies and Cellular Therapy Program, Dallas, Texas., Anderson L Jr; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Hematologic Malignancies and Cellular Therapy Program, Dallas, Texas., Forsberg P; UC Health Blood Disorders and Cell Therapies Center, Aurora, Colorado., Herr M; Roswell Park Comprehensive Cancer Center, Buffalo, New York., Hansen DK; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Hakan Kocoglu M; University of Maryland Marlene and Stewart Greenbaum Comprehensive Cancer Center, Baltimore, Maryland., Sborov D; Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah. |
| Source: | Transplantation and cellular therapy [Transplant Cell Ther] 2025 Dec; Vol. 31 (12), pp. 989-999. Date of Electronic Publication: 2025 Sep 17. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40972962 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Fludarabine Lymphodepletion Exposure is Associated with Toxicities after Idecabtagene-Vicleucel in Relapsed/Refractory Multiple Myeloma: Real-World Experience from the US Myeloma Immunotherapy Consortium. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sweiss+K%22">Sweiss K</searchLink>; University of Illinois at Chicago, Chicago, Illinois. Electronic address: ksweis2@uic.edu.<br /><searchLink fieldCode="AU" term="%22Wagner+C%22">Wagner C</searchLink>; Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah.<br /><searchLink fieldCode="AU" term="%22Anto+E%22">Anto E</searchLink>; Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah.<br /><searchLink fieldCode="AU" term="%22Greene+T%22">Greene T</searchLink>; Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah.<br /><searchLink fieldCode="AU" term="%22Sun+R%22">Sun R</searchLink>; University of Illinois at Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Gonzalez+R%22">Gonzalez R</searchLink>; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Puglianini+OC%22">Puglianini OC</searchLink>; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Freeman+C%22">Freeman C</searchLink>; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Ionescu+F%22">Ionescu F</searchLink>; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Patel+K%22">Patel K</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Ferreri+C%22">Ferreri C</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Gaballa+M%22">Gaballa M</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Shune+L%22">Shune L</searchLink>; The University of Kansas Medical Center, Kansas City, Kansas.<br /><searchLink fieldCode="AU" term="%22McGuirk+J%22">McGuirk J</searchLink>; The University of Kansas Medical Center, Kansas City, Kansas.<br /><searchLink fieldCode="AU" term="%22Sidana+S%22">Sidana S</searchLink>; Stanford University, Palo Alto, California.<br /><searchLink fieldCode="AU" term="%22Hovanky+V%22">Hovanky V</searchLink>; Stanford University, Palo Alto, California.<br /><searchLink fieldCode="AU" term="%22Khouri+J%22">Khouri J</searchLink>; Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Raza+S%22">Raza S</searchLink>; Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Anwer+F%22">Anwer F</searchLink>; Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Dima+D%22">Dima D</searchLink>; Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Hashmi+H%22">Hashmi H</searchLink>; Medical University of South Carolina, Charleston, South Carolina.<br /><searchLink fieldCode="AU" term="%22Davis+J%22">Davis J</searchLink>; Medical University of South Carolina, Charleston, South Carolina.<br /><searchLink fieldCode="AU" term="%22Afrough+A%22">Afrough A</searchLink>; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Hematologic Malignancies and Cellular Therapy Program, Dallas, Texas.<br /><searchLink fieldCode="AU" term="%22Kaur+G%22">Kaur G</searchLink>; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Hematologic Malignancies and Cellular Therapy Program, Dallas, Texas.<br /><searchLink fieldCode="AU" term="%22Anderson+L+Jr%22">Anderson L Jr</searchLink>; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Hematologic Malignancies and Cellular Therapy Program, Dallas, Texas.<br /><searchLink fieldCode="AU" term="%22Forsberg+P%22">Forsberg P</searchLink>; UC Health Blood Disorders and Cell Therapies Center, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Herr+M%22">Herr M</searchLink>; Roswell Park Comprehensive Cancer Center, Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22Hansen+DK%22">Hansen DK</searchLink>; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Hakan+Kocoglu+M%22">Hakan Kocoglu M</searchLink>; University of Maryland Marlene and Stewart Greenbaum Comprehensive Cancer Center, Baltimore, Maryland.<br /><searchLink fieldCode="AU" term="%22Sborov+D%22">Sborov D</searchLink>; Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101774629%22">Transplantation and cellular therapy</searchLink> [Transplant Cell Ther] 2025 Dec; Vol. 31 (12), pp. 989-999. <i>Date of Electronic Publication: </i>2025 Sep 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101774629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-6367 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226666367%22">26666367 </searchLink><i>NLM ISO Abbreviation: </i>Transplant Cell Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40972962 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jtct.2025.08.015 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 989 Titles: – TitleFull: Fludarabine Lymphodepletion Exposure is Associated with Toxicities after Idecabtagene-Vicleucel in Relapsed/Refractory Multiple Myeloma: Real-World Experience from the US Myeloma Immunotherapy Consortium. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sweiss K – PersonEntity: Name: NameFull: Wagner C – PersonEntity: Name: NameFull: Anto E – PersonEntity: Name: NameFull: Greene T – PersonEntity: Name: NameFull: Sun R – PersonEntity: Name: NameFull: Gonzalez R – PersonEntity: Name: NameFull: Puglianini OC – PersonEntity: Name: NameFull: Freeman C – PersonEntity: Name: NameFull: Ionescu F – PersonEntity: Name: NameFull: Patel K – PersonEntity: Name: NameFull: Ferreri C – PersonEntity: Name: NameFull: Gaballa M – PersonEntity: Name: NameFull: Shune L – PersonEntity: Name: NameFull: McGuirk J – PersonEntity: Name: NameFull: Sidana S – PersonEntity: Name: NameFull: Hovanky V – PersonEntity: Name: NameFull: Khouri J – PersonEntity: Name: NameFull: Raza S – PersonEntity: Name: NameFull: Anwer F – PersonEntity: Name: NameFull: Dima D – PersonEntity: Name: NameFull: Hashmi H – PersonEntity: Name: NameFull: Davis J – PersonEntity: Name: NameFull: Afrough A – PersonEntity: Name: NameFull: Kaur G – PersonEntity: Name: NameFull: Anderson L Jr – PersonEntity: Name: NameFull: Forsberg P – PersonEntity: Name: NameFull: Herr M – PersonEntity: Name: NameFull: Hansen DK – PersonEntity: Name: NameFull: Hakan Kocoglu M – PersonEntity: Name: NameFull: Sborov D IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2025 Dec Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2666-6367 Numbering: – Type: volume Value: 31 – Type: issue Value: 12 Titles: – TitleFull: Transplantation and cellular therapy Type: main |
| ResultId | 1 |
